CDK8 and chronic obstructive pulmonary disease: In conclusion, our findings provide a new perspective on the pathogenesis of COPD combined with AF from the viewpoint of the inflammatory immune response and suggest a biomarker CDK8 that could potentially be a therapeutic target.